M. Breyer (Vienna, Austria), D. Olivieri (Parma, Italy), K. Takeyama (Tokyo , Japan)
Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
H. Benabdelghaffar, O. Neffati, S. Fenniche, I. Akrout, D. Greb, L. Fekih, H. Hassene, T. Khmiss, D. Belhabib, M. L. Megdiche (Ariana, Tunisia)
|  |
The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction
B. Milenkovic, M. Andjic, I. Zivkovic, D. Bulatovic, M. Lazovic, T. Cvok, J. Jankovic (Belgrade, Republic Of Serbia)
|  |
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
V. Pinto-Plata, M. Divo, Y. Tesfaigzi, H. Peterson, V. Calhoum, D. Holloway, Y. Wang, C. Owen, B. Celli (Boston, Albuquerque, United States Of America)
| |
Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD
P. Pobeha, D. Petrasova, R. Tkacova, P. Joppa (Kosice, Slovakia)
| |
Determinants of severity of dyspnea in COPD
I. Trofimenko, B. Chernyak (Irkutsk, Russian Federation)
| |
Modified Medical Research Council questionnaire and COPD assessment test are inconsistent
Q. Zhang, C. Wang, Q. Ma (Chongqing, China)
| |
The relation of comorbidities with the exacerbation severity in patients with COPD
E. Özgür, S. Atis Nayci, C. Özge, Y. Duman, G. çavusoglu, A. Ilvan (Mersin, Turkey)
| |
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
P. R. Burgel, J. L. Paillasseur, M. Partridge, M. Miravitlles, M. Cazzola, C. Vogelmeier, D. Leynaud, J. Ostinelli, R. Kessler (Paris, Rueil-Malmaison, Strasbourg, France; London, United Kingdom; Barcelona, Spain; Rome, Italy; Marburg, Germany)
| |
Antagonism of substance P and perception of dyspnea in patients with COPD
D. Mahler, A. Gifford, L. Waterman, A. Gilani, B. Kupchak, W. Kraemer (Lebanon, Storrs, United States Of America)
| |
Clinical and inflammatory characteristics of 'unreported' COPD exacerbations
M. Calderazzo, M. B. Trujillo-Torralbo, S. Elkin, S. Johnston, P. Mallia (London, United Kingdom; Catanzaro, Italy)
| |
CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD
H. J. Prins, H. Daniels, W. Boersma (Alkmaar, Amsterdam, Netherlands)
| |
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
J. Piquet, J. M. Chavaillon, P. Ferrer-Lopez, L. Chemery, F. Sénéchal, N. Roche (Montfermeil, Antibes, Granville, Pontoise, Paris, France; Papeete, French Polynesia)
| |
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
E. Kochetova (Petrozavodsk, Russian Federation)
| |
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Endoplasmic reticulum stress, COPD and lung cancer
B. Nunez, S. Scrimini, A. Agusti, A. Iglesias, B. Cosio, M. Lopez, J. A. Torrecilla, J. Sauleda (Palma de Mallorca, Barcelona, Spain)
| |
Does 6 minute walk test predict nocturnal oxygen desaturation in COPD patients?
S. Iliaz, T. Cagatay, Z. Bingol, G. Okumus, G. Kuran, R. Iliaz, A. Dokme, F. Comce, E. Kiyan, Z. Kilicaslan, T. Ece, P. Cagatay (Istanbul, Turkey)
| |
The impact of COPD and life-style factors on the vitamin D status of a Swedish population
M. Kentson, P. Leanderson, P. Jacobson, M. Romanovic, U. Wennerström, L. Persson (Jönköping, Linköping, Västervik, Sweden)
| |
Effect of roflumilast on lung function: Results from 180-days study in subjects With severe COPD
M. Ostrovskyy, I. Savelikhina, O. Varunkiv, M. Kulynych-Miskiv, G. Korzh (Ivano-Frankivsk, Ukraine)
| |
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
A. Nowicka, B. Brajer-Luftmann, M. Kaczmarek, H. Batura-Gabryel (Poznan, Poland)
| |